Share on

Global Protein Labelling Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Labelling, Application & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2943
Pages: 175

Global Protein Labelling Market Size (2022 to 2027)

The global protein labelling market size is estimated to be worth USD 3.07 billion by 2027 from USD 1.73 billion in 2022, growing at a CAGR of 12.2% during the forecast period.

Protein labelling detects a labelled protein and its binding partners by using the proper molecular labels. Using labeling methods, different compounds, including biotin, reporter enzymes, and radioactive isotopes, are tightly bound to the target protein or nucleotide sequence. Proteins are the largest and most important biomolecules in a living organism, as they are essential for survival. Proteins interact with other biomolecules and carry out tasks to keep the cell alive after being produced within a cell. The usage of non-canonical amino acids (ncAAs) followed by conjugation of labeled protein with fluorophores, polymers, affinity reagents, peptides, or nanoparticles has been demonstrated to be successful in proteomics and biotechnology.

Protein labeling is becoming increasingly popular. Protein labelling employs a short label to prevent protein folding and function from being disturbed. Immunochemistry, fluorescence in situ hybridization (FISH), cell tracking, receptor tagging, and fluorescence spectroscopy are just a few of the uses for these fluorescent proteins. In addition, biological process monitoring, accurate compound quantification, precise detection of protein changes and isoforms in multiplexed samples, increased detection sensitivity, and simplified detection procedures are some of the most common uses for protein labeling use of IT technology is intended to automate and simplify research and development, as well as increase experimentation and research.


Innovation is playing a significant role in the global protein labelling market growth.

Chemically synthesized tags replace reagent and Kit-based protein labeling, probes, and tags through click chemistry and other newer and improved technologies. In addition, synergistic advances in optical physics, probe design, molecular biology, and computational analysis have resulted in the design and development of new protein-labeling technologies that have the potential to propel the future protein labeling market profitably.

Additionally, increasing health care awareness, rising R&D expenditure, growing technological advancements, innovative products, applications, and services, and the development of proteomics coupled with the development of protein sequencing techniques further accelerate the growth rate of the global protein labelling market. Moreover, computer-controlled fluorescence and laser-confocal microscopy systems are also creating scope for the market.

Increasing government's focus on improving the healthcare infrastructure, increasing proteomics research, and increasing research and development spending for the research activities are expected to provide a favorable environment for the global protein labelling market to explore further. Adopting modern molecular biology and bioengineering tools to intensify functional mechanism knowledge on a subcellular scale, under both pathologic and psychologic conditions, leads to drug development, diagnosis, and therapy applications. With the bioengineering tools, the usage label in the detection & purification of proteins and diagnostic tests based on detecting a particular protein has grown significantly.  The market represents several new product launches, and the rising adoption of bioengineering technologies is expected to accelerate the market growth.


However, a lack of skilled professionals and awareness and high product costs hinder the growth of the global protein labelling market.

Impact of COVID-19 on the global protein labeling market:

The current debacle of COVID-19, with a constantly clambering number of deaths across various nations, led to the nationwide lockdown. In the battle against the novel coronavirus, governments banned flights and other transportation to stop virus transmission from person to person. Due to the prohibition on transportation, the protein labeling market supply chain was disrupted.  The protein labeling market consists of products and related services sales of protein labeling products; because of the sudden implementation of lockdown and ban, no sales were made during the first quarter of 2020. As a result, there were some limitations on the exports and imports of protein labeling products.

However, the second quarter of 2020 acted favorably on the protein labelling market. The factors such as the uplift of lockdown resumed activities and increasing demand for the protein label products are expected to boost the market growth. Furthermore, post the outbreak, the market has completely changed; therefore, manufacturing industries manufacture the products as per the customers' needs. As a result, analysts at Market Data Forecast forecasted the global protein labelling market to return to its actual growth pace by 2021.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Analysed

By Product, Labelling, Application, and Region


Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies Analysed

Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.


This research report on the global protein labelling market has been segmented and sub-segmented based on the product, labelling, application, and region.

Protein Labelling Market - By Product:

  • Enzymes
  • Kits and Services

Based on Product, Reagents had the highest market share in 2020. In-vitro labelling accounted for a larger revenue share due to ongoing clinical investigation studies concerning the proteomic analysis of genetic data. As a result, an increase in the number of labeling agents and genetically engineered labels is discovered, expected to calculate the percentage of the reagents segment. The protein segment held a significant share for protein labeling in terms of revenue share in the reagent segment. 

Protein Labelling Market - By Labelling:

  • In vitro Labelling
  • In vivo Labelling

The vitro labeling segment is estimated to account for most market share during the forecast period based on the labeling. Reagents, instruments, and systems are intended for use in the diagnosis of diseases and other conditions. The in vitro labeling procedure takes approximately 25 minutes and doesn’t require centrifugation to separate from bound 99mtc.

Protein Labelling Market - By Application:

  • Cell-Based Assay
  • Mass Spectroscopy
  • Fluorescence Microscopy
  • immunological Technique
  • Protein Microarray

The Immunological techniques segment represents the largest segment with a higher market share based on the application. Flow cytometry, immunoassays, western blotting, and immunofluorescence are immunological techniques involved in using labels. These techniques are primarily used in cancer research, autoimmune disease research, and therapeutics development.

Protein Labelling Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on the Region, North America generated the highest revenue in 2020 and has the maximum share of the global protein labelling market due to the technological advancements, demand for protein labelling products, and rise in R&D investments. Furthermore, North America is estimated to dominate the global market, with Europe and Asia-Pacific in the line due to the significant rise in funding.

The Asia-Pacific is the fastest-growing region due to the increased demands of emerging economies such as Japan, India, and China, rising investment in genomic and proteomic research, and healthcare expenditure.


Some of the notable companies dominating the global protein labelling market profiled in this report are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.


  • Abcam, a UK-based developer, and distributor of protein research tools, said in January 2020 that it has agreed to buy Expedeon's Proteomics and Immunology division, which comprises Innova and TGR Biosciences.
  • Researchers from the National Institutes of Health (US) demonstrated the application of a bi-arsenical dye system that allows the fluorescence detection of proteins in various cellular locations was shown in August 2019 by researchers from the National Institutes of Health (US).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample